Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009–2020 - Scorecard - MDSpire

Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009–2020

  • By

  • Joseph-Kevin Igwe

  • Phani Keerthi Surapaneni

  • Erin Cruz

  • Cedric Cole

  • Kingsley Njoku

  • Jisoo Kim

  • Ugo Alaribe

  • Kelechi Weze

  • Bilal Mohammed

  • October 7, 2023

  • 0 min

Share

Clinical Scorecard: Trends and Outcomes of Bariatric Surgery in Patients with Inflammatory Bowel Disease: A Comparison of Sleeve Gastrectomy and Historical Bariatric Procedures in US Hospitals from 2009 to 2020

At a Glance

CategoryDetail
ConditionObesity with Inflammatory Bowel Disease (IBD)
Key MechanismsBariatric surgery reduces absorptive surface area and intrinsic factor production affecting micronutrient absorption; gut microbiome alterations influence metabolism and immune responses relevant to IBD
Target PopulationPatients with obesity (BMI > 35 kg/m2) and at least one obesity-related comorbidity, including those with IBD
Care SettingUS hospital settings performing metabolic and bariatric surgery

Key Highlights

  • Metabolic and bariatric surgery (MBS) such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) lead to micronutrient deficiencies through different mechanisms.
  • Gut-associated lymphoid tissue (GALT) and gut microbiome alterations play a significant role in immune regulation and pathogenesis of IBD.
  • Preoperative evaluation includes assessment of vitamin B12, folic acid, and other micronutrients critical for immune and metabolic functions.

Guideline-Based Recommendations

Diagnosis

  • Preoperative testing should include serum vitamin B12, folic acid, complete blood count, chemistry panel, lipid profile, liver and thyroid function, and coagulation tests.
  • Consider holotranscobalamin, methyl malonic acid, and homocysteine levels for borderline vitamin B12 cases (150–220 pmol/L).

Management

  • Monitor and manage micronutrient deficiencies postoperatively, especially vitamin B12 due to decreased intrinsic factor production.
  • Recognize that both SG and RYGB have similar micronutrient deficiency profiles despite different surgical mechanisms.

Monitoring & Follow-up

  • Regular follow-up for micronutrient levels including vitamin B12 and others to prevent deficiency-related complications.
  • Monitor gut microbiome changes as they may influence weight loss outcomes and IBD disease activity.

Risks

  • Micronutrient deficiencies including vitamin B12 deficiency due to altered absorption post-MBS.
  • Potential exacerbation or modulation of IBD due to changes in gut microbiota and immune responses after surgery.

Patient & Prescribing Data

Obese patients with or without inflammatory bowel disease undergoing bariatric surgery

Both sleeve gastrectomy and Roux-en-Y gastric bypass are effective for weight loss but require careful monitoring for micronutrient deficiencies and immune-related complications in IBD patients.

Clinical Best Practices

  • Conduct comprehensive preoperative micronutrient screening including vitamin B12 and folate.
  • Implement postoperative supplementation and monitoring protocols tailored to the type of bariatric surgery performed.
  • Consider the impact of altered gut microbiota and immune function in patients with IBD undergoing bariatric surgery.
  • Use additional biomarkers (holotranscobalamin, methyl malonic acid, homocysteine) to assess borderline vitamin B12 status.
  • Educate patients on the importance of adherence to micronutrient supplementation and follow-up.

References

Original Source(s)

Related Content